SELLAS Life Sciences SLS
NASDAQ SLS
$11.33 -0.98 (-7.96%)
At close: Oct 1, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Non Operating Income (2012 - 2026)

Updated

SELLAS Life Sciences' Non Operating Income came in at $1.02 million for Q2 2026, up 276.5% from $272,000 a year earlier and up 21.2% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Non Operating Income (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, SELLAS Life Sciences reported Non Operating Income of $2.76 million, up 198.5% year-over-year; for FY2025, it was $1.41 million, up 123.3% from FY2024.

  • Non Operating Income carries a five-year compound annual growth rate of 46.7% (FY2020 to FY2025).
  • Going back by year, Non Operating Income was $632,000 in FY2024 (+19.5%), $529,000 in FY2023 (-18.5%), $649,000 in FY2022 (-85.1%) and $4.36 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Non Operating Income since Q4 2014.
  • Year-over-year, Non Operating Income has increased for eight consecutive quarters, with growth averaging 193.7% over the last eight quarters.
  • The fastest year-over-year change in Non Operating Income over five years came in Q4 2024 (growth of 341.5%), and the weakest in Q4 2023 (a decline of 87.4%).
  • Business Quant data shows SLS's Non Operating Income at $845,000 (Q1 2026), $597,000 (Q4 2025) and $292,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 SELLAS Life Sciences 2.49 Bn 2.49 Bn - 1.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Mn
Mar 31, 2026 845,000.00
Dec 31, 2025 597,000.00
Sep 30, 2025 292,000.00
Jun 30, 2025 272,000.00
Mar 31, 2025 250,000.00
Dec 31, 2024 181,000.00
Sep 30, 2024 221,000.00
Jun 30, 2024 151,000.00
Mar 31, 2024 79,000.00
Dec 31, 2023 41,000.00
Sep 30, 2023 94,000.00
Jun 30, 2023 210,000.00
Mar 31, 2023 184,000.00
Dec 31, 2022 325,000.00
Sep 30, 2022 124,000.00
Jun 30, 2022 209,000.00
Dec 31, 2019 -7.50 Mn
Sep 30, 2019 -4.20 Mn
Jun 30, 2019 -3.13 Mn
API Access

SELLAS Life Sciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLS&period=max&api_key=YOUR_API_KEY